Article: Evaluation and treatment of enuresis.
2008 Volume 78, Issue 4, Page(s) 489–496
Abstract: Enuresis is defined as repeated, spontaneous voiding of urine during sleep in a child five years or older. It affects 5 to 7 million children in the United States. Primary nocturnal enuresis is caused by a disparity between bladder capacity and nocturnal ...
Abstract | Enuresis is defined as repeated, spontaneous voiding of urine during sleep in a child five years or older. It affects 5 to 7 million children in the United States. Primary nocturnal enuresis is caused by a disparity between bladder capacity and nocturnal urine production and failure of the child to awaken in response to a full bladder. Less commonly, enuresis is secondary to a medical, psychological, or behavioral problem. A diagnosis usually can be made with a history focusing on enuresis and a physical examination followed by urinalysis. Imaging and urodynamic studies generally are not needed unless specifically indicated (e.g., to exclude suspected neurologic or urologic disease). Primary nocturnal enuresis almost always resolves spontaneously over time. Treatment should be delayed until the child is able and willing to adhere to the treatment program; medications are rarely indicated in children younger than seven years. If the condition is not distressing to the child, treatment is not needed. However, parents should be reassured about their child's physical and emotional health and counseled about eliminating guilt, shame, and punishment. Enuresis alarms are effective in children with primary nocturnal enuresis and should be considered for older, motivated children from cooperative families when behavioral measures are unsuccessful. Desmopressin is most effective in children with nocturnal polyuria and normal bladder capacity. Patients respond to desmopressin more quickly than to alarm systems. Combined treatment is effective for resistant cases. |
---|---|
MeSH term(s) | Algorithms ; Antidepressive Agents, Tricyclic/therapeutic use ; Antidiuretic Agents/therapeutic use ; Behavior Therapy ; Child ; Combined Modality Therapy ; Deamino Arginine Vasopressin/therapeutic use ; Enuresis/diagnosis ; Enuresis/epidemiology ; Enuresis/therapy ; Humans ; Imipramine/therapeutic use ; Practice Guidelines as Topic ; Precipitating Factors ; Treatment Outcome |
Chemical Substances | Antidepressive Agents, Tricyclic ; Antidiuretic Agents ; Deamino Arginine Vasopressin (ENR1LLB0FP) ; Imipramine (OGG85SX4E4) |
Language | English |
Publishing date | 2008-08-15 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 412694-4 |
ISSN | 0002-838X ; 0572-3612 |
ISSN | 0002-838X ; 0572-3612 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 848: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.